EUVIMEDOpdag EUVIMED
Crossref

Clozapine‐induced third‐degree atrioventricular block and respiratory failure

Y. W. Francis Lam

The Brown University Psychopharmacology Update · 2026-04 · 37 (4) · 2-2

DOI: 10.1002/pu.31426 ↗

At a glance

Journal article in The Brown University Psychopharmacology Update, published online on 2026-03-14. Written by Y. W. Francis Lam. 2 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The atypical antipsychotic clozapine is highly effective for patients with treatment‐resistant schizophrenia. However, its well‐recognized side‐effect profile, including severe toxicity such as agranulocytosis, limits its use. Significant cardiopulmonary adverse effects also have been associated with clozapine.

Cite

APA

Lam, Y. W. F. (2026). Clozapine‐induced third‐degree atrioventricular block and respiratory failure. The Brown University Psychopharmacology Update, 37(4), 2-2. https://doi.org/10.1002/pu.31426

Vancouver

Lam YWF. Clozapine‐induced third‐degree atrioventricular block and respiratory failure. The Brown University Psychopharmacology Update. 2026;37(4):2-2. doi:10.1002/pu.31426

BibTeX
@article{Lam2026,
  author = {Lam, Y. W. Francis},
  title = {Clozapine‐induced third‐degree atrioventricular block and respiratory failure},
  journal = {The Brown University Psychopharmacology Update},
  year = {2026},
  volume = {37},
  number = {4},
  pages = {2--2},
  doi = {10.1002/pu.31426}
}
Start for free →